CYP26: Key Player in Drug Metabolism and Natural Compounds (P12972)

Target Name: Cytochrome P450 26

NCBI ID: P12972

Cytochrome P450 26

Other Name(s): CYP26

CYP26: Key Player in Drug Metabolism and Natural Compounds

Cytochrome P450 26 (CYP26) is a gene that encodes for a protein known as the cytochrome P450 enzyme 26. This enzyme is a key player in the metabolism of drugs and other compounds, and is involved in the production of many important compounds in the body.

CYP26 is a nonspecific subtype of the cytochrome P450 enzyme family, which includes 26 different subtypes. These subtypes are different in their structure and function, and play different roles in the metabolism of different compounds. CYP26 is one of the most well-studied of the CYP26 subtypes, and is involved in the metabolism of a wide range of drugs and other compounds.

One of the key functions of CYP26 is its role in the metabolism of drugs. Many drugs work by interacting with the CYP26 enzyme and altering its activity. This can lead to changes in the way the drug is metabolized and how it is distributed throughout the body . In some cases, this can result in the drug becoming more potent or less effective, while in other cases it may cause unexpected side effects or toxicity.

Another important function of CYP26 is its role in the production of natural compounds that are important for many different physiological processes in the body. These compounds, known as metabolites, are produced by the body as it metabolizes different substances. CYP26 is involved in the production of many of these metabolites, including steroids, progestins, and other compounds that are important for growth, development, and other physiological processes.

CYP26 is also involved in the production of other important compounds that are used for diagnostic and therapeutic purposes. For example, CYP26 is often used as a marker for the diagnosis of liver disease, as it is expressed at higher levels in the liver than in other tissues. CYP26 is also used as a biomarker for several diseases, including cancer, cardiovascular disease, and neurological disorders.

Despite its important functions, CYP26 is a relatively small molecule and is not a common target for drug development. However, its role in the metabolism of drugs and other compounds, as well as its involvement in the production of natural compounds and biomarkers, make it a promising target for future research.

In conclusion, CYP26 is a nonspecific subtype of the cytochrome P450 enzyme family that is involved in the metabolism of drugs and other compounds, as well as the production of natural compounds and biomarkers. Its role in these processes makes it a promising target for future research , and its potential as a drug target or biomarker should be further explored.

Protein Name: Cytochrome P450 26 (nonspecified Subtype)

The "Cytochrome P450 26 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Cytochrome P450 26 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets